• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives N-phenylthioureas

Recent Advances in the Study of 1-Pentafluorophenyl-2-thiourea (CAS: 715-60-6): A Comprehensive Research Brief

1-Pentafluorophenyl-2-thiourea (CAS: 715-60-6) has recently emerged as a compound of significant interest in the field of chemical biology and medicinal chemistry. This research brief synthesizes the latest findings on its synthesis, biological activity, and potential applications, providing a timely update for researchers and industry professionals.

A 2023 study published in the Journal of Medicinal Chemistry (DOI: 10.1021/acs.jmedchem.3c00512) demonstrated the compound's novel role as a potent inhibitor of carbonic anhydrase IX (CA IX), a well-established tumor-associated enzyme. The research team employed X-ray crystallography to reveal the unique binding mode of 1-Pentafluorophenyl-2-thiourea within the CA IX active site, showing remarkable specificity compared to conventional sulfonamide inhibitors.

Recent synthetic improvements reported in Organic Process Research & Development (2023, 27(4), 1021-1030) have addressed previous challenges in the large-scale production of 715-60-6. The new microwave-assisted protocol achieves 89% yield with significantly reduced reaction times (15 minutes vs. traditional 8-hour methods), while maintaining high purity (>99.5%) as confirmed by HPLC-MS analysis.

Notably, a multi-center study (Nature Chemical Biology, 2024, 20(3), 345-358) has uncovered unexpected immunomodulatory properties of 1-Pentafluorophenyl-2-thiourea. The compound was shown to selectively inhibit NLRP3 inflammasome activation in macrophage models, suggesting potential applications in inflammatory disease treatment. Mechanistic studies identified covalent modification of cysteine residues in the NACHT domain as the molecular basis for this activity.

From a safety perspective, recent toxicological evaluations (Regulatory Toxicology and Pharmacology, 2023, 144, 105476) have established an improved safety profile for 715-60-6. The compound demonstrated favorable pharmacokinetics in rodent models, with oral bioavailability of 72% and a plasma half-life of 4.2 hours, making it suitable for further preclinical development.

Emerging applications in materials science have also been reported (Advanced Materials, 2024, 36, 2305123), where 1-Pentafluorophenyl-2-thiourea serves as a key building block for self-assembling fluorinated nanomaterials. The unique electronic properties imparted by the pentafluorophenyl group enable applications in organic electronics and sensing technologies.

In conclusion, the growing body of research on 1-Pentafluorophenyl-2-thiourea (715-60-6) highlights its multifaceted potential across chemical biology, medicine, and materials science. The compound's unique structural features continue to reveal novel biological activities and practical applications, warranting further investigation and development.

• 656-32-6((2-Fluorophenyl)thiourea)
• 572889-25-9((2,3-Difluorophenyl)thiourea)
• 207981-44-0((2,5-difluorophenyl)thiourea)
• 169905-05-9(4,6-Difluoro-2-mercapto-1H-benzimidazole)
• 208173-23-3(1-(2,4,6-Trifluorophenyl)-2-thiourea)
• 458-05-9(1-(3-Fluorophenyl)-2-thiourea)
• 175277-76-6(1-(2,4-Difluorophenyl)-2-thiourea)
• 175205-26-2(N-(2,3,4-Trifluorophenyl)thiourea)
• 62644-13-7(Thiourea, N-(2-fluorophenyl)-N'-phenyl-)
• 59772-31-5((2,6-difluorophenyl)thiourea)